Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-12-16FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals, indicating a labeling-related update fo…
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Study of the Use of Low Level Laser Therapy to Reduce Acne [NA]
A completed clinical trial sponsored by Erchonia Corporation evaluated low level laser therapy as a treatment to reduce acne; results were p…
-
CLINICAL_TRIALS withdrawal · 2015-12-03Clinical Trial Update: Efficacy of Handheld Acne Heat Device [Phase 4]
Phase 4 trial evaluating a handheld acne heat device for acne vulgaris has been withdrawn from the registry.
-
FDA approval · 2015-11-19FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC.
-
FDA approval · 2015-10-08FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-21FDA Approved: DOXYCYCLINE HYCLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Doxycycline Hyclate by Hikma Pharmaceuticals USA Inc., indicating a change to the product's labe…
-
FDA approval · 2015-09-21FDA Approved: CLINDAMYCIN AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a new generic clindamycin and benzoyl peroxide topical product from Padagis Israel Pharmaceuticals Ltd for the treatment of acn…
-
FDA approval · 2015-09-18FDA Approved: ERYTHROMYCIN AND BENZOYL PEROXIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic topical combination product of erythromycin and benzoyl peroxide for acne under ANDA065385 by Rising Pharma Holdings,…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris [Phase 2]
A Phase 2 trial assessing the safety and efficacy of CLS001 Topical Gel versus vehicle in inflammatory acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris [Phase 3]
This document describes a Phase 3 clinical trial comparing IDP-121 to IDP-121 Vehicle Lotion for acne vulgaris. The current status of the tr…
-
CLINICAL_TRIALS research · 2015-09-14Clinical Trial Update: A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 clinical trial comparing IDP-121 to vehicle lotion for acne vulgaris; status is unknown from the provided snippet.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris [Phase 2]
This clinical trial update reports on a Phase 2 study evaluating the efficacy and safety of IDP-120 Gel for acne vulgaris.
-
CLINICAL_TRIALS research · 2015-09-14Clinical Trial Update: Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris [Phase 2]
This update describes a Phase 2 study comparing the safety and efficacy of IDP-123 Lotion to Tazorac Cream for acne vulgaris.
-
FDA approval · 2015-09-10FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC.
-
FDA approval · 2015-09-03FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approves a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals.
-
FDA approval · 2015-09-03FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries.
-
FDA approval · 2015-09-03FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for ZENATANE (isotretinoin) from BluePoint Laboratories.
-
FDA approval · 2015-09-03FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2015-09-03FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc., indicating a modification or additi…
-
FDA approval · 2015-09-03FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Padagis Israel Pharmaceuticals Ltd to market a generic clindamycin phosphate and benzoyl peroxid…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris [Phase 4]
Phase 4 study update on dapsone gel for acne vulgaris in females with skin of color; the trial has completed and results were posted in 2015…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel [Phase 4]
Phase 4 trial comparing tolerability of adapalene-benzoyl peroxide gel versus tretinoin gel for acne vulgaris; results posted after completi…
-
FDA approval · 2015-08-13FDA Approved: TRETINOIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's original application for tretinoin (generic), making a generic tretinoin product available via ANDA.
-
FDA approval · 2015-07-20FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2015-07-20FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for CLARAVIS (isotretinoin), enhancing the product's approved labeling.